Donald J. D'Amico

TL;DR: The vitreous levels of the angiogenic polypeptide vascular endothelial growth factor were measured and compared in eyes with and without proliferative diabetic retinopathy, and these data are consistent with vascular endothelium growth factor serving as a physiologically relevantAngiogenic factor in proliferative diabetes Retinopathy.

TL;DR: In this phase II trial, subjects assigned to pegaptanib had better VA outcomes, were more likely to show reduction in central retinal thickness, and were deemed less likely to need additional therapy with photocoagulation at follow-up.

TL;DR: In this paper, the authors report the predisposing factors, timing of symptoms, diagnosis, causative organisms, source of infection, and visual outcome in cases of endogenous bacterial endophthalmitis.

TL;DR: The appearance of new uveitic entities, such as the acute retinal necrosis syndrome, multifocal choroiditis and panuveitis, birdshot retinochoroidopathy, and acquired immunodeficiency syndrome-related uveitis, and the reemergence of the classic infectious causes of uveita, tuberculosis and syphilis, have changed the way the diagnosis and management of posterior andPanuveitis at the Massachusetts Eye and Ear Infirmary.

TL;DR: The purpose of this document is to identify specific strategies for the delivery of IVT injection that may reduce risks and improve outcomes, and to identify outstanding issues in need of further investigation.